ERBB2 and breast carcinoma: Breast cancer is classified into several sub-types according to immunohistochemistry markers: estrogen receptor (ER) positive (luminal subtype), human epidermal growth factor receptor-2 (HER2) positive and triple-negative (basal-like) [2,8].